Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
4.40
Ask:
4.525
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Change

8 Jun 2011 07:00

RNS Number : 0183I
Seeing Machines Limited
08 June 2011
 



8 June 2011

SEEING MACHINES (the "Company")

 

CEO TO DEPART AT END OF CONTRACT

Seeing Machines Limited (AIM:SEE), a leading developer of advanced vision based industrial systems, announces today that CEO and Director Dr Nick Cerneaz will leave the Company in July 2011.

Dr Cerneaz has been with the Company since 2005 and took over as CEO in September 2005 and led the Company at the time of its listing on AIM in December 2005. For the six years that he has been with the company he has commuted to the Canberra head office from his home in Sydney where he lives with his wife and young family. Dr Cerneaz and the Board of Seeing Machines have agreed his tenure as CEO will conclude at the end of this contract. Dr Cerneaz has also agreed to assist the Company in a consulting capacity throughout a handover period as required.

The Board is currently conducting a search for a replacement to lead the Company, as it seeks to move through the next phase of growth and commercialisation. Seeing Machines manufactures a range of world leading products from fatigue management tools through to 3D visualisation and medical technologies, and the Board remains committed to driving a strategy of growth through commercialisation of these technologies and products.

Dr Cerneaz commented: "I have very much enjoyed the efforts and contribution I have made at Seeing Machines and greatly valued the opportunity to work with such a dedicated, professional and energetic team. We have successfully moved the Company through an extensive period of development and laid the foundations for tremendous commercial success ahead, particularly with significant contracts established in our DSS and faceAPI businesses and strong pipelines ahead. I wish to take this opportunity to thank all my colleagues and the stakeholders in the business that have encouraged and supported our efforts and wish the company well in its forward endeavours."

Chairman Bill Mobbs commenting on Dr Cerneaz's departure said: "The Board is extremely grateful to Nick for his leadership of the Company throughout his tenure which was characterised by strong commitment, professionalism, drive and enthusiasm in taking the Company forward. We wish Nick well in his future endeavours and join with everyone at Seeing Machines in thanking Nick wholeheartedly for his efforts on behalf of the Company. "

Enquiries:

Seeing Machines Limited

Bill Mobbs, Chairman

+61 (0) 2 6103 4700

Daniel Stewart & Company plc

Oliver Rigby

+44 (0) 20 7776 6550

Walbrook PR Ltd

 

Paul McManus

 

Paul Cornelius

+44 (0) 20 7933 8780+44 (0) 7980 541 893, paul.mcmanus@walbrookpr.com

+44 (0) 7866 384 707, paul.cornelius@walbrookir.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGMGGVDNRGMZM
Date   Source Headline
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.